Concepedia

Jeffrey VanValkenburgh

JV

5

Publications

262

Citations

5

H-Index

2010

Active since

Affiliations

Albany Medical Center Hospital(Current)

Institute of Molecular and Cell Biology

Wellcome Sanger Institute

Center for Cancer Research

Jeffrey VanValkenburgh is an author at Albany Medical Center Hospital specializing in immunotherapy, cell signaling, and t cell immunity.

Top concepts

Publications per year

2010–2020

5

Publications

5

Critical role of Bcl11b in suppressor function of T regulatory cells and prevention of inflammatory bowel disease

Jeffrey VanValkenburgh, Diana I. Albu, Chandra Bapanpally et al. · The Journal of Experimental Medicine · 2011 · 77 citations · Full text

Antigen-specific clonal expansion and cytolytic effector function of CD8+ T lymphocytes depend on the transcription factor Bcl11b

Shuning Zhang, Mike Rozell, Raj Kumar Verma et al. · The Journal of Experimental Medicine · 2010 · 55 citations · Full text

Diverting T helper cell trafficking through increased plasticity attenuates autoimmune encephalomyelitis

Danielle Califano, Keith Sweeney, Hung Lê et al. · Journal of Clinical Investigation · 2013 · 49 citations · Full text

, , +23

Transcription factor Bcl11b controls selection of invariant natural killer T-cells by regulating glycolipid presentation in double-positive thymocytes

Diana I. Albu, Jeffrey VanValkenburgh, Nicole A. Morin et al. · Proceedings of the National Academy of Sciences · 2011 · 46 citations · Full text

Enhanced IL-36R signaling promotes barrier impairment and inflammation in skin and intestine

Zaruhi Hovhannisyan, Nengyin Liu, Sara Khalil-Agüero et al. · Science Immunology · 2020 · 35 citations

Rows per page

1–5 of 5